Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study location entry was updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-05T06:19:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as the condition, included the Genetic and Rare Diseases Information Center as a resource, and updated the location entry from Napoli to Naples, Campania, Italy (80131) with revision to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T16:51:58.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No study content or usability aspects appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-07T05:26:43.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed the sponsor link 'Click here to find results for studies related to Bayer Healthcare products' from the Bayer Helpful Links section. This change does not affect the core study details, eligibility criteria, or outcomes presented on the page.
    Difference
    0.0%
    Check dated 2026-02-20T20:26:55.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Minor site revision updated from v3.4.1 to v3.4.2 with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:24:23.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Minor site version update from v3.4.0 to v3.4.1 with no visible changes to the study details page, eligibility criteria, or results; to avoid alerts from small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:12:05.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.